Outcome of cardiac surgery for carcinoid heart disease

Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota 55905.

OBJECTIVES. The hypothesis was that cardiac surgery for symptomatic carcinoid heart disease in conjunction with adjunctive therapy could improve the long-term outlook of patients with carcinoid heart disease. BACKGROUND. Patients with carcinoid heart disease have a dismal prognosis; most die of progressive right heart failure within 1 year after onset of symptoms. Improved therapies for the systemic manifestations of the carcinoid syndrome have resulted in symptomatic improvement and prolonged survival in patients without heart disease. METHODS. Twenty-six patients with symptomatic carcinoid heart disease underwent valvular surgery. Preoperative clinical, laboratory, Doppler echocardiographic and hemodynamic factors were evaluated. The survival of the surgical group was compared with that of a control group of 40 medically treated patients. RESULTS. There were nine perioperative deaths (35%), primarily from postoperative bleeding and right ventricular failure. Of the 17 surgical survivors, 8 were alive at a mean of 28 months of follow-up. The postoperative functional class of the eight surviving patients was substantially improved. Late deaths were primarily due to hepatic dysfunction caused by metastatic disease. The only predictor of operative mortality (p = 0.03) was low voltage on preoperative electrocardiography (limb lead voltage < or = 5 mm). Predictors of late survival included a lower preoperative somatostatin requirement and a lower preoperative urinary 5-hydroxy-indoleacetic acid level. There was a trend toward increased survival for the surgical group compared with the control group. CONCLUSIONS. Because new therapies have improved survival in patients with the malignant carcinoid syndrome, cardiac involvement has become a major cause of morbidity and mortality. Valve surgery is the only definitive treatment. Although cardiac surgery carries a high perioperative mortality, marked symptomatic improvement occurs in survivors. Surgical intervention should therefore be considered when cardiac symptoms become severe.

This article has been cited by other articles:

				J. K. Ramage, A. Ahmed, J. Ardill, N. Bax, D. J. Breen, M. E. Caplin, P. Corrie, J. Davar, A. H. Davies, V. Lewington, et al. Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs) Gut, January 1, 2012; 61(1): 6 - 32. [Abstract] [Full Text] [PDF]

				S. Bhattacharyya, S. G. Raja, C. Toumpanakis, M. E. Caplin, G. D. Dreyfus, and J. Davar Outcomes, risks and complications of cardiac surgery for carcinoid heart disease Eur J Cardiothorac Surg, July 1, 2011; 40(1): 168 - 172. [Abstract] [Full Text] [PDF]

				S. Bhattacharyya, M. Burke, M. E. Caplin, and J. Davar Utility of 3D transoesophageal echocardiography for the assessment of tricuspid and pulmonary valves in carcinoid heart disease Eur Heart J Cardiovasc Imaging, January 1, 2011; 12(1): E4 - E4. [Abstract] [Full Text] [PDF]

				A. L. Clark 27 Right heart failure Oxford Textbook of Heart Failure, January 1, 2011; 1(1): med-9780199577729-chapter - med-9780199577729-chapter. [Abstract] [Full Text]

				J. G. Castillo and G. Silvay Characterization and Management of Cardiac Tumors Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2010; 14(1): 6 - 20. [Abstract] [PDF]

				C. K Choong, J. E Arrowsmith, A. A Klein, and F. C Wells Transannular Pulmonary Enlargement and Bioprostheses for Carcinoid Disease Asian Cardiovasc Thorac Ann, October 1, 2009; 17(5): 510 - 512. [Abstract] [Full Text] [PDF]

				J. G. Castillo, F. Filsoufi, D. H. Adams, J. Raikhelkar, B. Zaku, and G. W. Fischer Management of patients undergoing multivalvular surgery for carcinoid heart disease: the role of the anaesthetist Br. J. Anaesth., November 1, 2008; 101(5): 618 - 626. [Abstract] [Full Text] [PDF]

				J. G. Castillo, F. Filsoufi, P. B. Rahmanian, A. Anyanwu, J. S. Zacks, R. R.P. Warner, and D. H. Adams Early and Late Results of Valvular Surgery for Carcinoid Heart Disease J. Am. Coll. Cardiol., April 15, 2008; 51(15): 1507 - 1509. [Full Text] [PDF]

				H. V. Schaff and R. M. Suri Multiple Valve Disease Card. Surg. Adult, January 1, 2008; 3(2008): 1129 - 1158. [Full Text]

				S. Bhattacharyya, J. Davar, G. Dreyfus, and M. E. Caplin Carcinoid Heart Disease Circulation, December 11, 2007; 116(24): 2860 - 2865. [Full Text] [PDF]

				O. Gonzalez, M. T. Alberca, and C. Santonja Echocardiographic diagnosis of carcinoid disease: Exceptional evolution after ovarian tumor resection without cardiac surgery Eur Heart J Cardiovasc Imaging, December 1, 2007; 8(6): 497 - 500. [Abstract] [Full Text] [PDF]

				F. Majeed, T. R. Porter, S. Tarantolo, A. Duhachek-Stapelman, F. Xie, and A. Elhendy Carcinoid crisis and reversible right ventricular dysfunction after embolization in untreated carcinoid syndrome Eur Heart J Cardiovasc Imaging, October 1, 2007; 8(5): 386 - 389. [Abstract] [Full Text] [PDF]

				J. E. Moller, P. A. Pellikka, A. M. Bernheim, H. V. Schaff, J. Rubin, and H. M. Connolly Prognosis of Carcinoid Heart Disease: Analysis of 200 Cases Over Two Decades Circulation, November 22, 2005; 112(21): 3320 - 3327. [Abstract] [Full Text] [PDF]

				P. G. Voigt, J. Braun, O. Y. Teng, D. R. Koolbergen, E. Holman, J. J. Bax, V. T.H.B.M. Smit, and R. A.E. Dion Double Bioprosthetic Valve Replacement in Right-Sided Carcinoid Heart Disease Ann. Thorac. Surg., June 1, 2005; 79(6): 2147 - 2149. [Abstract] [Full Text] [PDF]

				D. J Fox and R. S Khattar Carcinoid heart disease: presentation, diagnosis, and management Heart, October 1, 2004; 90(10): 1224 - 1228. [Full Text] [PDF]

				H. V. Schaff and D. H. Marsh Multiple Valve Disease Card. Surg. Adult, January 1, 2003; 2(2003): 1017 - 1045. [Full Text]

				H. M. Connolly, H. V. Schaff, C. J. Mullany, M. D. Abel, and P. A. Pellikka Carcinoid Heart Disease: Impact of Pulmonary Valve Replacement in Right Ventricular Function and Remodeling Circulation, September 24, 2002; 106(12_suppl_1): I-51 - I-56. [Abstract] [Full Text] [PDF]

				J. A. Caccitolo, H. M. Connolly, D. S. Rubenson, T. A. Orszulak, and H. V. Schaff Operation for anorexigen-associated valvular heart disease J. Thorac. Cardiovasc. Surg., October 1, 2001; 122(4): 656 - 664. [Abstract] [Full Text] [PDF]

				H. M. Connolly, H. V. Schaff, C. J. Mullany, J. Rubin, M. D. Abel, and P. A. Pellikka Surgical Management of Left-Sided Carcinoid Heart Disease Circulation, September 18, 2001; 104(2009): I-36 - I-40. [Abstract] [Full Text] [PDF]

				M. A. O. Kinney, M. E. Warner, D. M. Nagorney, J. Rubin, D. R. Schroeder, P. M. Maxson, and M. A. Warner Perianaesthetic risks and outcomes of abdominal surgery for metastatic carcinoid tumours{dagger} Br. J. Anaesth., September 1, 2001; 87(3): 447 - 452. [Abstract] [Full Text] [PDF]

				S. Fischer, M. Kruger, K. McRae, N. Merchant, M. S. Tsao, and S. Keshavjee Giant bronchial carcinoid tumors: a multidisciplinary approach Ann. Thorac. Surg., January 1, 2001; 71(1): 386 - 393. [Abstract] [Full Text] [PDF]

				O Obel, D J Coltart, and M Signy Balloon pulmonary valvuloplasty in carcinoid syndrome Heart, December 1, 2000; 84(6): 13e - 13. [Abstract] [Full Text]

				A. Holdcroft Hormones and the gut Br. J. Anaesth., July 1, 2000; 85(1): 58 - 68. [Full Text] [PDF]

				S D Johnston, P W Johnston, and D O'Rourke Carcinoid constrictive pericarditis Heart, November 1, 1999; 82(5): 641 - 643. [Abstract] [Full Text]

				W. D. Denney, W. E. Kemp Jr., L. B. Anthony, J. A. Oates, and B. F. Byrd III Echocardiographic and biochemical evaluation of the development and progression of carcinoid heart disease J. Am. Coll. Cardiol., October 1, 1998; 32(4): 1017 - 1022. [Abstract] [Full Text] [PDF]